The global Clavulanic Acid Market is poised to experience a consistent and steady compound annual growth rate (CAGR) in revenue over the projected period. This growth can be predominantly attributed to the extensive use of clavulanic acid in hospitals and drug stores as a highly effective antibiotic for the treatment of bacterial infections, including sinus and respiratory tract infections.
Clavulanic acid, a semi-synthetic beta-lactamase inhibitor derived from Streptomyces, possesses a beta-lactam ring that strongly binds to beta-lactamase near its active site, thereby inhibiting its enzymatic activities. Consequently, other beta-lactam antibiotics are shielded from beta-lactamase degradation, enhancing their antibacterial properties. To combat infections caused by beta-lactamase-producing organisms, clavulanic acid is administered in combination with beta-lactam antibiotics such as penicillin and cephalosporins. The preference for this product over alternatives stems from its minimal impact on patient weight and blood sugar levels following administration.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5740
The surge in demand for clavulanic acid can be attributed to its availability in two forms: tablets and liquid-filled capsules, both of which can be taken orally, providing patients with flexibility in their treatment options. Furthermore, tablets are available in various dosage quantities, simplifying the treatment process and ensuring patient convenience. The increasing incidence of bacterial infections is a significant driver of revenue growth in the clavulanic acid market during the forecast period.
Key Factors Driving Revenue Growth in the Global Clavulanic Acid Market:
The growing prevalence of antibiotic-resistant bacteria is a primary factor propelling the clavulanic acid market's growth. The pharmaceutical industry's increased demand for the product can be linked to rising cases of bacterial diseases and a heightened emphasis on healthcare. The surge in demand is further driven by the prevalence of infections such as sinusitis, middle ear infections, and respiratory tract infections, which are commonly treated with clavulanic acid in combination with amoxicillin. Additionally, the product is favored for its rapid onset of action, providing immediate relief. The increased utilization of clavulanic acid in treating bacterial infections contributes to the market's revenue growth during the forecast period.
Opportunities for Players in the Global Clavulanic Acid Market:
The increasing focus on healthcare and growing awareness of antibiotics present significant opportunities for market revenue growth. The World Health Organization (WHO) published a comprehensive list in 2017, detailing major bacteria responsible for diseases and the corresponding antibiotics needed for treatment, including clavulanic acid in combination with amoxicillin. The rising awareness of bacterial diseases is likely to lead to more diagnoses, thereby increasing demand for the product. Greater healthcare awareness will promote the use of clavulanic acid, creating opportunities for market revenue growth.
Global Clavulanic Acid Market Revenue Growth by Type Segment:
The global clavulanic acid market is categorized into two segments: tablets and capsules. Tablets are expected to dominate the market in terms of revenue share during the forecast period. Tablets are easy to manufacture and store, making them a preferred choice for patients. The increased demand for tablets can also be attributed to the need for long-term use, given the resistance of bacteria and the requirement for lower, evenly spaced doses to enhance treatment efficacy. Oral tablets are relatively safer, reducing the risk of accidental overdose. Tablets for clavulanic acid are more cost-effective than injections, enhancing treatment accessibility and driving demand. The extensive use of tablets in treating bacterial infections is expected to further boost demand and contribute to revenue growth over the forecast period.
Global Clavulanic Acid Market Leading Application Segment:
In terms of application, the global clavulanic acid market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to witness significant revenue growth during the forecast period, driven by the consistent use of antibiotics in treating various diseases and infections. These medications are not available for purchase without a prescription from a medical practitioner and are approved by the U.S. Food and Drug Administration (FDA), enhancing their credibility in hospitals. The increasing incidence of bacterial infections worldwide implies a demand for antibiotics, leading to rising demand for clavulanic acid for hospital treatments. This surge in demand is expected to contribute to revenue growth in the market.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5740
The Asia Pacific Market to Lead in Global Clavulanic Acid Market Revenue Share:
The Asia Pacific market is anticipated to experience the highest revenue growth during the forecast period, primarily due to the rapid increase in cases of bacterial infections in the region. Rising demand for the product can be attributed to its extensive use as an antibiotic for respiratory and sinus infections. China and India are currently the largest manufacturers and exporters of antibiotics, holding approximately 70% of the market share. The increased concern about diseases such as sinusitis and the lack of antiviral medications make antibiotics, like clavulanic acid, a viable option for containment. Authorities in the region have taken effective measures to improve healthcare infrastructure, driving demand for the product and revenue growth in the market.
North America Continues to Lead in Terms of Revenue CAGR:
The North American market is expected to maintain a steady revenue CAGR over the forecast period. The region has witnessed a rising number of bacterial infections, and increased awareness of these infections, their symptoms, and treatments is expected to boost demand for clavulanic acid. For example, a study conducted by the National Ambulatory Medical Care Survey (NAMCS) in 2022 reported that sinus infections affect 1 out of 7 adults in the U.S., equivalent to 30 million diagnosed patients annually. The increasing prevalence of such cases is likely to drive demand for clavulanic acid in the region during the forecast period.
Major Companies in the Market:
Several major companies operate in the global clavulanic acid market, including GSK Pvt. Ltd. (U.K.), Novartis Sandoz Group AG (Switzerland), Sinopharm Sandwich Dayao Ye Ltd. (China), Shandong New Time Pharmaceutical Ltd. (China), B. Chemicals Pharmaceuticals Ltd. (India), United Laboratories Pvt. Ltd. (China), CSPC Pharmaceutical Group Ltd. (China), Sun Pharmaceutical Industries Ltd (U.S.), North China Pharmaceutical Group Ltd. (China), and Medopharm Group Pvt. Ltd. (India).
Strategies and Objectives of Major Companies:
In June 2022, B. Chemicals Pharmaceuticals Ltd. officially announced its acquisition of four brands from Dr. Reddy’s Laboratories, one of which is Pecef Duo, manufacturing Cefpodoxime Proxetil Clavulanic Acid Potassium Salt, to provide antibiotics for the growing bacterial infections in the market.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5740
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Bronchiectasis Treatment Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
